Asthma in Patients With Japanese Cedar Pollinosis

被引:0
|
作者
Tanaka, Akihiko [1 ]
Minoguchi, Kenji [2 ]
Pawankar, Ruby [3 ]
Adachi, Mitsuru [1 ]
机构
[1] Showa Univ, Div Allergy & Resp Med, Dept Internal Med, Tokyo, Japan
[2] Sumiregaoka Clin, Yokohama, Kanagawa, Japan
[3] Nippon Med Sch, Tokyo, Japan
来源
WORLD ALLERGY ORGANIZATION JOURNAL | 2012年 / 5卷
关键词
Japanese cedar pollinosis; asthma; allergic rhinitis;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea, nasal obstruction, nasal itching, and itching of the eyes. Previous reports indicate that the prevalence of Japanese cedar pollinosis among Japanese was 26.5%. According to a more recent questionnaire-based survey, the prevalence of Japanese cedar pollinosis in patients with adult asthma might be up to 30% to 50%, suggesting higher rates than that previously reported. Moreover, 30% to 60% of adult asthmatic patients with concomitant pollinosis have exacer-bations of their asthma symptoms during the Japanese cedar pollen season. These findings suggest that concomitant Japanese cedar pollinosis may be an aggravating factor in patients with asthma. As with other pollens, such as grass and birch, Japanese cedar pollen was shown to be a trigger factor for worsening asthma. In clinical practice, a number of Japanese patients with asthma are mono-sensitized to Japanese cedar pollen but not to other antigens. Further studies are needed to elucidate the mechanisms of Japanese cedar pollen in inducing and in exacerbating asthma. The presence of concomitant AR is often associated with the difficulty in asthma control. However, there has been a controversy whether treating concomitant AR by intranasal corticosteroid would produce better asthma-related outcomes in patients with asthma and AR. The effect of treating concomitant cedar pollinosis by intranasal corticosteroids on asthma control in patients with asthma and cedar pollinosis also remains unknown. Certain systemic treatments, such as leukotriene receptor antagonist and anti-IgE monoclonal antibody, are supposed to reduce the symptoms of both asthma and AR in patients with asthma and concomitant AR. In conclusion, Japanese cedar pollinosis is often associated with exacerbations of asthma. Further investigations are expected to elucidate the precise impact and mechanisms of Japanese cedar pollinosis in asthma.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis
    Hamada, Satoko
    Kobayashi, Yoshiki
    Sakamoto, Daiki
    Shimamura, Akihiro
    Kuroda, Kazumichi
    Kawachi, Risaki
    Kanda, Akira
    Asako, Mikiya
    Gotoh, Minoru
    Okubo, Kimihiro
    Tomoda, Koichi
    Iwai, Hiroshi
    AURIS NASUS LARYNX, 2021, 48 (04) : 646 - 652
  • [2] Efficacy and Safety of Sublingual Immunotherapy for Two Seasons in Patients with Japanese Cedar Pollinosis
    Okamoto, Yoshitaka
    Okubo, Kimihiro
    Yonekura, Syuji
    Hashiguchi, Kazuhiro
    Goto, Minoru
    Otsuka, Takashi
    Murata, Tadayuki
    Nakao, Yuji
    Kanazawa, Chigiri
    Nagakura, Hitoshi
    Okawa, Toru
    Nakano, Koichi
    Hisamitsu, Minako
    Kaneko, Shinya
    Konno, Akiyoshi
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2015, 166 (03) : 177 - 188
  • [3] Effect of Asian sand dust on Japanese cedar pollinosis
    Ogi, Kazuhiro
    Takabayashi, Tetsuji
    Sakashita, Masafumi
    Susuki, Dai
    Yamada, Takechiyo
    Manabe, Yasuhiro
    Fujieda, Shigeharu
    AURIS NASUS LARYNX, 2014, 41 (06) : 518 - 522
  • [4] Association of Japanese cedar pollinosis and sensitization with HLA-DPB1 in the Japanese adolescent
    Morii, Wataru
    Sakai, Aiko
    Ninomiya, Takahiro
    Kidoguchi, Masanori
    Sumazaki, Ryo
    Fujieda, Shigeharu
    Noguchi, Emiko
    ALLERGOLOGY INTERNATIONAL, 2018, 67 (01) : 61 - 66
  • [5] Development of immunotherapies for Japanese cedar pollinosis
    Sakaguchi, Masahiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 69 - 72
  • [6] Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis
    Kikuoka, Hirotaka
    Kouzaki, Hideaki
    Matsumoto, Koji
    Arai, Hiroyuki
    Yamamoto, Sayuri
    Tojima, Ichiro
    Shimizu, Shino
    Miyashita, Hiromi
    Ogawa, Yukiko
    Osada, Toshihiro
    Okano, Mitsuhiro
    Yuta, Atsushi
    Shimizu, Takeshi
    CLINICAL IMMUNOLOGY, 2020, 210
  • [7] Relationship between airborne pollen count and treatment outcome in Japanese cedar pollinosis patients
    Takasaki, Kenji
    Enatsu, Kaori
    Kumagami, Hidetaka
    Takahashi, Haruo
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2009, 266 (05) : 673 - 676
  • [8] Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis
    Fujii, Tatsuya
    Kitamura, Yoshiaki
    Kamimura, Seiichiro
    Naito, Keisuke
    Takeda, Noriaki
    AURIS NASUS LARYNX, 2021, 48 (04) : 653 - 658
  • [9] An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients
    Imanaka, Takahiro
    Sato, Izumi
    Kawasaki, Yohei
    Kanazawa, Yuji
    Kawakami, Koji
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2019, 9 (06) : 615 - 623
  • [10] Analysis of natural history of Japanese cedar pollinosis
    Okawa, T
    Konno, A
    Yamakoshi, T
    Numata, T
    Terada, N
    Shima, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2003, 131 (01) : 39 - 45